These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18537875)

  • 1. ABCB1-1Delta polymorphism can predict hematologic toxicity in dogs treated with vincristine.
    Mealey KL; Fidel J; Gay JM; Impellizeri JA; Clifford CA; Bergman PJ
    J Vet Intern Med; 2008; 22(4):996-1000. PubMed ID: 18537875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of vincristine-associated myelosuppression in Border Collies.
    Lind DL; Fidel JL; Gay JM; Mealey KL
    Am J Vet Res; 2013 Feb; 74(2):257-61. PubMed ID: 23363351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ABCB1-1Delta mutation is not responsible for subchronic neurotoxicity seen in dogs of non-collie breeds following macrocyclic lactone treatment for generalized demodicosis.
    Bissonnette S; Paradis M; Daneau I; Silversides DW
    Vet Dermatol; 2009 Feb; 20(1):60-6. PubMed ID: 19152588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vincristine-induced central neurotoxicity in a collie homozygous for the ABCB1Δ mutation.
    Krugman L; Bryan JN; Mealey KL; Chen A
    J Small Anim Pract; 2012 Mar; 53(3):185-7. PubMed ID: 22122243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breed distribution of the ABCB1-1Delta (multidrug sensitivity) polymorphism among dogs undergoing ABCB1 genotyping.
    Mealey KL; Meurs KM
    J Am Vet Med Assoc; 2008 Sep; 233(6):921-4. PubMed ID: 18795852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABCB1-1 Delta (MDR1-1 Delta) genotype is associated with adverse reactions in dogs treated with milbemycin oxime for generalized demodicosis.
    Barbet JL; Snook T; Gay JM; Mealey KL
    Vet Dermatol; 2009 Apr; 20(2):111-4. PubMed ID: 19171022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of potential biomarkers of P-glycoprotein substrate neurotoxicity in transgenic mice expressing the mutated canine ABCB1 gene.
    Zhu M; Ming Y; Swaim H; Swain MD; Myers MJ; Deaver C; Wu X; Jones YL; Yancy HF
    Am J Vet Res; 2014 Dec; 75(12):1104-10. PubMed ID: 25419811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous fat emulsion as treatment for ivermectin toxicosis in three dogs homozygous for the ABCB1-1Δ gene mutation.
    Wright HM; Chen AV; Talcott PA; Poppenga RH; Mealey KL
    J Vet Emerg Crit Care (San Antonio); 2011 Dec; 21(6):666-72. PubMed ID: 22316260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breed is associated with the ABCB1-1Δ mutation in Australian dogs.
    Soussa RW; Woodward A; Marty M; Cannon CM
    Aust Vet J; 2020 Mar; 98(3):79-83. PubMed ID: 31743433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canine ABCB1 and macrocyclic lactones: heartworm prevention and pharmacogenetics.
    Mealey KL
    Vet Parasitol; 2008 Dec; 158(3):215-22. PubMed ID: 18922637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of the ABCB1-1Δ gene mutation in a sample of New Zealand Huntaway dogs.
    Gedye K; Poole-Crowe E; Shepherd M; Wilding A; Parton K; Lopez-Villalobos N; Cave N
    N Z Vet J; 2023 May; 71(3):133-136. PubMed ID: 36786530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loperamide-induced expression of immune and inflammatory genes in Collies associated with ivermectin sensitivity.
    Zhu M; Yancy HF; Deaver C; Jones YL; Myers MJ
    J Vet Pharmacol Ther; 2016 Apr; 39(2):131-7. PubMed ID: 26471945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral bioavailability of P-glycoprotein substrate drugs do not differ between ABCB1-1Δ and ABCB1 wild type dogs.
    Mealey KL; Waiting D; Raunig DL; Schmidt KR; Nelson FR
    J Vet Pharmacol Ther; 2010 Oct; 33(5):453-60. PubMed ID: 20840389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biliary excretion of technetium-99m-sestamibi in wild-type dogs and in dogs with intrinsic (ABCB1-1Delta mutation) and extrinsic (ketoconazole treated) P-glycoprotein deficiency.
    Coelho JC; Tucker R; Mattoon J; Roberts G; Waiting DK; Mealey KL
    J Vet Pharmacol Ther; 2009 Oct; 32(5):417-21. PubMed ID: 19754906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of the Canine ABCB1-1Δ Mutation on Sedation after Intravenous Administration of Acepromazine.
    Deshpande D; Hill KE; Mealey KL; Chambers JP; Gieseg MA
    J Vet Intern Med; 2016; 30(2):636-41. PubMed ID: 26822006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between ABCB1 genotype and seizure outcome in Collies with epilepsy.
    Muñana KR; Nettifee-Osborne JA; Bergman RL; Mealey KL
    J Vet Intern Med; 2012; 26(6):1358-64. PubMed ID: 22998209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic modeling of doxorubicin pharmacokinetics in dogs deficient in ABCB1 drug transporters.
    Gustafson DL; Thamm DH
    J Vet Intern Med; 2010; 24(3):579-86. PubMed ID: 20337920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotoxic effects of ivermectin administration in genetically engineered mice with targeted insertion of the mutated canine ABCB1 gene.
    Orzechowski KL; Swain MD; Robl MG; Tinaza CA; Swaim HL; Jones YL; Myers MJ; Yancy HF
    Am J Vet Res; 2012 Sep; 73(9):1477-84. PubMed ID: 22924731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PREVALENCE OF THE
    Stafford EG; Harrison T; Kortum A; Mealey KL
    J Zoo Wildl Med; 2021 Jan; 51(4):1007-1011. PubMed ID: 33480582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of prevalence, genetic aspects and adverse effects of the mdr1-1Delta mutation in dogs.
    Fecht S; Distl O
    Dtsch Tierarztl Wochenschr; 2008 Jun; 115(6):212-9. PubMed ID: 18605373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.